Its worth noting that only Zepbound, Wegovy, and Foundayo are FDA-approved for weight loss and management
Cell Viability Assay Cell viability was determined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
At the end of the day, its a supplement patch posing as medical care
Ideal Candidates: Adults over 35-40 with significant weight to lose (30+ pounds) and declining natural hormone levels Individuals who have tried multiple conventional approaches without sustained success Those with metabolic syndrome or prediabetes seeking aggressive intervention People prioritizing body composition (muscle-to-fat ratio) over simple scale weight Patients willing to commit to regular bloodwork, medical supervision, and lifestyle modifications Poor Candidates: Anyone with personal or family history of medullary thyroid cancer or MEN2 syndrome Individuals with active cancer or history of hormone-sensitive cancers Those with severe kidney or liver disease Pregnant or breastfeeding women People seeking a quick fix without commitment to lifestyle change Anyone unwilling or unable to afford ongoing costs and monitoring Accessing These Compounds in Canada The regulatory landscape for these compounds in Canada differs from the United States and creates specific considerations for Canadian residents interested in this protocol
23, Novo executives said CagriSema still has the potential to deliver the highest weight loss of any drug on the market after its expected approval by the Food and Drug Administration by the end of 2026 and launch in 2027
Here's how CBC News also asked Health Canada if it has received an application for a pill form of Wegovy from Novo Nordisk, or a generic version of the medication in pill form
